Decline in Quantitative Serum HBsAg Level during Consolidation Therapy Following HBeAg Loss in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir

被引：0
|
作者：
Su, Wen-Pang [1 ]
Peng, Cheng-Yuan [1 ]
Lai, Hsueh-Chou [1 ]
Lin, Chia-Hsin [1 ]
Chuang, Po-Heng [1 ]
Chen, Sheng-Hung [1 ]
机构：
[1] China Med Univ Hosp, Taichung, Taiwan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1875
引用
收藏
页码：1102A / 1103A
页数：2
相关论文
共 50 条
  • [21] VIROLOGICAL RESPONSE AT 12 WEEKS OF ENTECAVIR THERAPY PREDICTS HBeAg CLEARANCE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS
    Song, B. -C
    Chae, H. B.
    Kim, Y. N.
    Lee, B. S.
    Cho, Y. -K
    JOURNAL OF HEPATOLOGY, 2009, 50 : S237 - S237
  • [22] Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B
    Kwon, J. H.
    Jang, J. W.
    Lee, S.
    Lee, J.
    Chung, K. W.
    Lee, Y. S.
    Choi, J. Y.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (02) : E41 - E47
  • [23] Association of KIR Genotypes and Haplotypes in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir
    Zhuang, YunLong
    Li, XiXi
    Li, Xiaohua
    Xu, HuiCong
    Ye, Hui
    Sun, Di
    Liu, XiangZhong
    Ren, GuiJie
    IMMUNOLOGICAL INVESTIGATIONS, 2019, 48 (04) : 333 - 344
  • [24] Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation
    Peng, Cheng-Yuan
    Chen, Chih-Bin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Wu, Hong-Dar Isaac
    Jeng, Long-Bin
    HEPATOLOGY INTERNATIONAL, 2011, 5 (01) : 586 - 596
  • [25] Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation
    Cheng-Yuan Peng
    Chih-Bin Chen
    Hsueh-Chou Lai
    Wen-Pang Su
    Po-Heng Chuang
    Hong-Dar Isaac Wu
    Long-Bin Jeng
    Hepatology International, 2011, 5 : 586 - 596
  • [26] Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients
    Bradshaw, D.
    Danta, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (09) : 992 - 992
  • [27] Maintenance of virologic response during consolidation therapy with lamivudine in HBeAg-positive chronic hepatitis B patients
    Yoon, K. T.
    Kim, Y. M.
    Heo, J.
    Choi, C. W.
    Kim, H. W.
    Kang, D. H.
    Cho, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A190 - A190
  • [28] MAINTENANCE OF VIROLOGIC RESPONSE DURING CONSOLIDATION THERAPY WITH LAMIVUDINE IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS
    Yoon, Ki Tae
    Kim, Yeong Muk
    Heo, Jeong
    Cho, Mong
    HEPATOLOGY, 2009, 50 (04) : 523A - 523A
  • [29] PREDICTION OF RESPONSE TO PEGINTERFERON FOR HBEAG-POSITIVE CHRONIC HEPATITIS B USING QUANTITATIVE SEROLOGY: HBEAG VERSUS HBSAG
    Sonneveld, M. J.
    Rijckborst, V.
    Hansen, B. E.
    Janssen, H. L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S215 - S216
  • [30] Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients
    Keshvari, Maryam
    Alavian, Seyed Moayed
    Sharafi, Heidar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (03)
12345